Emergence of G9 P[6] human rotaviruses in Argentina: Phylogenetic relationships among G9 strains

被引:50
作者
Bok, K
Palacios, G
Sijvarger, K
Matson, D
Gomez, J
机构
[1] Natl Inst Infect Dis, Viral Gastroenteritis Lab, Buenos Aires, DF, Argentina
[2] Natl Inst Infect Dis, Neuroviruses Div, Buenos Aires, DF, Argentina
[3] Reg Hosp, Cent Lab, Ushuaia, Argentina
[4] Childrens Hosp Kings Daughters, Eastern Virginia Med Sch, Ctr Pediat Res, Norfolk, VA USA
关键词
D O I
10.1128/JCM.39.11.4020-4025.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Because rotavirus diarrhea can be reduced through vaccination and because current vaccine candidates provide protection against only the most common G antigenic types (G1 to G4), detection of uncommon G types is one of the main goals of rotavirus surveillance. After a 2-year nationwide rotavirus surveillance study in Argentina concluded, surveillance was continued and an increase of G9 prevalence in several Argentine cities was detected. During this period G9 strains predominated in the south, and a gradient of decreasing G9 prevalence was observed from south to north (41 to 0%). Sequence analysis of gene 9, encoding the G antigen, showed that Argentine strains cluster with most G9 isolates from other countries, showing less than 2% nucleotide divergence among them, but are distinctive from them in that they present some unique amino acid changes. Our results agree with reports of increased G9 prevalence in other parts of the world, suggesting the need to incorporate G9 into candidate rotavirus vaccines.
引用
收藏
页码:4020 / 4025
页数:6
相关论文
共 36 条
[1]  
[Anonymous], J INFECT DIS S
[2]  
Argüelles MH, 2000, J CLIN MICROBIOL, V38, P252
[3]   Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial [J].
Bernstein, DI ;
Sack, DA ;
Rothstein, E ;
Reisinger, K ;
Smith, VE ;
O'Sullivan, D ;
Spriggs, DR ;
Ward, RL .
LANCET, 1999, 354 (9175) :287-290
[4]   DEVELOPMENT OF CANDIDATE ROTAVIRUS VACCINES [J].
BISHOP, RF .
VACCINE, 1993, 11 (02) :247-254
[5]   Surveillance for rotavirus in Argentina [J].
Bok, K ;
Castagnaro, N ;
Borsa, A ;
Nates, S ;
Espul, C ;
Fay, O ;
Fabri, A ;
Grinstein, S ;
Miceli, I ;
Matson, DO ;
Gómez, JA .
JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (01) :190-198
[6]  
Bok K., 1999, Revista Argentina de Microbiologia, V31, P1
[7]   G and P genotyping of rotavirus strains circulating in France over a three-year period: Detection of G9 and P[6] strains at low frequencies [J].
Bon, F ;
Fromantin, C ;
Aho, S ;
Pothier, P ;
Kohli, E .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1681-1683
[8]   Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants [J].
Clements-Mann, ML ;
Makhene, MK ;
Mrukowicz, J ;
Wright, PF ;
Hoshino, Y ;
Midthun, K ;
Sperber, E ;
Karron, R ;
Kapikian, AZ .
VACCINE, 1999, 17 (20-21) :2715-2725
[9]   CHARACTERIZATION OF THE G-SEROTYPE AND GENOGROUP OF NEW-DELHI NEWBORN ROTAVIRUS STRAIN-116E [J].
DAS, BK ;
GENTSCH, JR ;
HOSHINO, Y ;
ISHIDA, SI ;
NAKAGOMI, O ;
BHAN, MK ;
KUMAR, R ;
GLASS, RI .
VIROLOGY, 1993, 197 (01) :99-107
[10]   IDENTIFICATION OF GROUP-A ROTAVIRUS GENE-4 TYPES BY POLYMERASE CHAIN-REACTION [J].
GENTSCH, JR ;
GLASS, RI ;
WOODS, P ;
GOUVEA, V ;
GORZIGLIA, M ;
FLORES, J ;
DAS, BK ;
BHAN, MK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (06) :1365-1373